Nefazodone for Mood Disorder Associated With Epilepsy
J Clin Psychiatry 1998;59:690 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Sir: Nefazodone, a newer antidepressant with a dual action on the serotonin system, is effective in major depression, comorbid anxiety and depression, and possibly other conditions such as panic disorder. It is a relatively safe drug with a favorable side effect profile, and its favorable effect on sleep has been documented. The present case is the first reported that demonstrates another possible indication of nefazodone: mood disorder associated with a general medical condition, in this case, seizure.